ScholarIQanswers from OpenAlex
Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC
PaperCitations, authors & open-access status
Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC have?
ScholarIQcitation count
Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC has 287 citations in the OpenAlex counts ScholarIQ stores.
When was Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC published?
ScholarIQyear
Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC has 2020 year in the ScholarIQ index.
What is the open-access status of Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC?
ScholarIQoa status
Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC has closed oa status in the ScholarIQ index.
What is the OpenAlex record for Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC?
ScholarIQopenalex
The OpenAlex for Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC is on the source record.